EPISEEK by Precision Epigenomics

About the Test

The Precision Epigenomics Liquid Biopsy Test, EPISEEK, is a blood-based test designed to detect circulating tumor DNA (ctDNA) from a simple blood draw. EPISEEK analyzes epigenomic modifications present on the ctDNA. Special software is used to analyze the results and aids the pathologist to issue a report that specifies if an abnormal signal is detected or if no cancer signal is detected. PLEASE NOTE: The sample must be received by the lab within 48 hours of collection.

Biomarkers

Circulating Tumor DNA

Biomarker name

Related Articles

Related Tests

PSA, Total (mcr Scr)

 by 

Access Med Labs

Serum

This is a single-marker test measuring total PSA. It is useful for monitoring recurrence and response to treatment in patients with a history of prostate cancer. Elevated levels have been reported in inflammatory conditions of the prostate, benign prostatic hypertrophy, and prostate cancer.

PSA Free and Total

 by 

Access Med Labs

Serum

This test measures free and total prostate-specific antigen (PSA).

3X4 Genetics Test + Blueprint Report

 by 

3X4 Genetics

Swab

The 3X4 Genetics Test + Blueprint Report provides 36 key insights and practical, personalized recommendations for patients to start taking control of their health.

PSA, Free and Total

 by 

Labcorp

Serum

This test measures free and total prostate-specific antigen (PSA).

MTHFR

 by 

Cell Science Systems

Swab

This test detects variations in the MTHFR gene. This is the swab version of the test. If ordered with an Alcat or other Cell Science Systems blood test, the blood version of this test will be sent.